A Multi-Institutional Randomized Phase III Trial of Neoadjuvant Chemoimmunotherapy Followed By Surgery Versus Upfront Surgery in Patients With Resectable Clinical Stage II-III Non-Small Cell Lung Cancer: JCOG2317 (NATCH-ICI)

Authors:

Abstract
No abstract available
Funding Information
  • Japan Agency for Medical Research and Development (JP25ck0106028)

This publication has 16 references indexed in Scilit: